Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Open-market buy Director bought 250,000 shares at $18.00 ($4,500,000)
  2. 4 Open-market buy 10% owner bought 300,000 shares at $18.00 ($5,400,000)
  3. 4 Conversion Director acquired 4,429,788 shares (conversion)
  4. 4 Conversion 10% owner acquired 4,429,788 shares (conversion)
  5. 4 Open-market buy 10% owner bought 277,777 shares at $18.00 ($4,999,986)
  6. 4 Conversion Director acquired 5,419,040 shares (conversion)
  7. 4 Conversion 10% owner acquired 5,419,040 shares (conversion)
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Open-market buy Former 10% owner bought 200,000 shares at $18.00 ($3,600,000)
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13D Stake Beneficial Ownership Report
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 424B4 Offering Prospectus
  20. CT ORDER Other Confidential Order

Page 34 of 37 · 725 filings